The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | 33.6x | 20.1x | Near average | |
Growth | 77 | 7.6% | 5.6% | Above average | |
Quality | 42 | 19.8% | 7.6% | Near average | |
Safety | 33 | 3.5x | 0.4x | Below average | |
Capital Return | 22 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Amneal Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Amneal Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
AMRX stock saw stability in the average price target at $17.33, with a new analyst entering coverage over the last 30 days, bringing the total number of analysts to 5. The price range ($16 - $19) reflects low dispersion among analysts, indicating high consensus on the stock's fair value, which exceeds the current price by approximately 34%.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.